|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/436 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2762140 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14164565.5 |
| Date of filing the European patent application | 2002-02-18 | |
| (97) | Date of publication of the European application | 2014-08-06 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-22 |
| (46) | Date of publication of the claims translation | 2017-06-26 |
| (30) | Number | Date | Country code |
| 0104072 | 2001-02-19 | GB | |
| 0124957 | 2001-10-17 | GB |
| (72) |
Lane, Heidi, CH
O`Reilly, Terence, CH
Wood, Jeanette Marjorie, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Solidinių smegenų navikų gydymas rapamicino dariniu |
| Treatment of solid brain tumours with a rapamycin derivative |
| Payment date | Validity (years) | Amount | |
| 2020-01-30 | 19 | 347.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2020-10-10 |